MRSA earnings per share for the last quarter are 126.96 EUR whereas the estimation was 87.86 EUR which accounts for 44.50% surprise. Company revenue for the same period amounts to 14.04 B EUR despite the estimated figure of 13.31 B EUR. Estimated earnings per share for the next quarter are 60.50 EUR, and revenue is expected to reach 12.68 B EUR. Also watch annual changes over time to get a bigger picture of MRSA earnings per share and revenue dynamics.